secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CIK:        0001100682
Form:       8-K
Filed at:   2023-11-08T23:59:59+00:00
Accession:  0001157523-23-001678
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Charles River Q3 results beat; narrows and raises non-GAAP EPS guidance for 2023
--------------------------------------------------------------------------------

- Q3 revenue $1.03B (+3.8% YoY); GAAP EPS $1.69 (-10.1%), non-GAAP EPS $2.72 (+3.4%).
- Organic revenue growth 4.1%, driven by DSA (+5.3% organic) and RMS (+3.2% organic).
- DSA segment GAAP operating margin down to 22.1% from 22.9%; non-GAAP up to 27.2% from 26.2%.
- RMS GAAP op margin 15.2% vs 19.9% prior; Manufacturing op margin down on GAAP and non-GAAP basis.
- FY2023 guidance: organic rev growth 5.5%-6.5% (narrowed from 5.5%-7.5%); non-GAAP EPS $10.50-$10.70 (prior $10.30-$10.90).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1100682/000115752323001678/0001157523-23-001678-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1100682/000115752323001678/a53773748.htm
  HTML page:      https://secwatch.observer/filing/0001157523-23-001678

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer